| 2009 EANM parathyroid guidelines E Hindié, Ö Ugur, D Fuster, M ODoherty, G Grassetto, P Ureña, A Kettle, ... European journal of nuclear medicine and molecular imaging 36, 1201-1216, 2009 | 393 | 2009 |
| Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of … Ö Ugur, PJ Kothari, RD Finn, P Zanzonico, S Ruan, I Guenther, ... Nuclear medicine and biology 29 (2), 147-157, 2002 | 155 | 2002 |
| Comparison of99mTc(V)-DMSA,201Tl and99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid Ö Uğur, L Kostakoğlu, N Güler, B Caner, U Uysal, N Elahi, M Hafloğlu, ... European journal of nuclear medicine 23, 1367-1371, 1996 | 108 | 1996 |
| Evaluation of osteoblastic activity in extraction sockets treated with platelet-rich fibrin O Baslarli, C Tumer, O Ugur, B Vatankulu Medicina oral, patologia oral y cirugia bucal 20 (1), e111, 2015 | 99 | 2015 |
| Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in osteosarcoma and its metastatic lymph nodes. B Caner, M Kitapçi, T Aras, G Erbengi, O Uğur, C Bekdik Journal of Nuclear Medicine: Official Publication, Society of Nuclear …, 1991 | 98 | 1991 |
| Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery N Arslan, S Ilgan, D Yuksel, M Serdengecti, N Bulakbasi, O Ugur, ... Clinical nuclear medicine 26 (8), 683-688, 2001 | 71 | 2001 |
| Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer M Caglar, FM Bozkurt, CK Akca, SE Vargol, M Bayraktar, O Ugur, ... Nuclear medicine communications 33 (3), 268-274, 2012 | 59 | 2012 |
| Intra-arterial radionuclide therapies for liver tumors MF Bozkurt, BV Salanci, Ö Uğur Seminars in Nuclear Medicine 46 (4), 324-339, 2016 | 53 | 2016 |
| Sentinel lymph node detection in early stage cervical cancer: a prospective study comparing preoperative lymphoscintigraphy, intraoperative gamma probe, and blue dye PP Kara, A Ayhan, B Caner, M Gültekin, O Ugur, MF Bozkurt, A Usubutun Annals of nuclear medicine 22, 487-494, 2008 | 52 | 2008 |
| Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? M Dietlein, K Scheidhauer, E Voth, P Theissen, H Schicha Nuklearmedizin-NuclearMedicine 37 (01), 06-11, 1998 | 51 | 1998 |
| The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake M Tuncel, D Aydin, E Yaman, UH Tazebay, D Güç, AL Doğan, ... Cancer biotherapy & radiopharmaceuticals 22 (3), 443-449, 2007 | 44 | 2007 |
| Impaired lung epithelial permeability in diabetics detected by technetium-99m-DTPA aerosol scintigraphy B Caner, O Ugur, M Bayraktar, N Ulutuncel, T Mentes, F Telatar, C Bekdik Journal of Nuclear Medicine 35 (2), 204-206, 1994 | 44 | 1994 |
| Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT M Silindir, S Erdoğan, AY Özer, AL Doğan, M Tuncel, Ö Uğur, VP Torchilin Journal of Liposome Research 23 (1), 20-27, 2013 | 43 | 2013 |
| Clinicopathologic and radiopharmacokinetic factors affecting gamma probe–guided parathyroidectomy O Ugur, MF Bozkurt, E Hamaloglu, C Sokmensuer, I Etikan, Y Ugur, ... Archives of surgery 139 (11), 1175-1179, 2004 | 42 | 2004 |
| Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy GK Gedik, Ö Uğur, B ATIlla, M Pekmezci, M Yildirim, B Seven, E VaroĞlu Annals of nuclear medicine 20, 183-188, 2006 | 41 | 2006 |
| Dobutamine thallium-201 myocardial SPECT in patients with left bundle branch block and normal coronary arteries B Caner, C Rezaghi, U Uysal, L Tokgozoglu, G Kabakci, N Elahi, S Kes, ... Journal of Nuclear Medicine 38 (3), 424-427, 1997 | 40 | 1997 |
| Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses O Ugur, L Kostakoglu, ET Hui, DR Fisher, K Garmestani, OA Gansow, ... Nuclear medicine and biology 23 (1), 1-8, 1996 | 36 | 1996 |
| Functional nuclear medicine imaging of medullary thyroid cancer MF Bozkurt, Ö Ugur, E Banti, G Grassetto, D Rubello Nuclear medicine communications 29 (11), 934-942, 2008 | 35 | 2008 |
| Optimization of the gamma probe-guided parathyroidectomy MF Bozkurt, O Ugur, E Hamaloglu, I Sayek, SA Gulec The American Surgeon 69 (8), 720-725, 2003 | 35 | 2003 |
| Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma O GUR, L Kostakoglu, B Caner, N Güler, NCM Gülaldi, M Özmen, U Uysal, ... Nuclear medicine communications 17 (5), 373-377, 1996 | 29 | 1996 |
Murat Fani BozkurtHacettepe University Faculty of Medicine在 hacettepe.edu.tr 的电子邮件经过验证
